相关实验视频

Updated: Jun 13, 2025

In Silico Identification and Characterization of circRNAs During Host-Pathogen Interactions

In Silico Identification and Characterization of circRNAs During Host-Pathogen Interactions

Published on: October 21, 2022

C2CDB:一个先进的平台,整合了癌症相关circRNAs的全面信息和分析工具

Yuanli Zuo¹, Wenrong Liu¹, Yang Jin¹

¹Laboratory of Molecular Oncology, Frontiers Science Center for Disease-related Molecular Network, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu 610064, China.

Bioinformatics advances

|September 9, 2024

概括

一个新的数据库,C2CDB,为癌症相关的循环RNA (circRNAs) 提供了全面的数据和分析工具. 本资源整合了各种信息,以推进对瘤发生中的circRNAs的研究.

科学领域:

基因组学就是基因组学.
生物信息学是一种生物信息学.
癌症研究癌症研究

背景情况:

循环RNAs (circRNAs) 越来越多地被认为是它们在基因表达和瘤发生中的作用.
现有的circRNA数据库缺乏专门针对癌症相关circRNA的综合信息和分析工具.

研究的目的:

开发一个全面的平台,CircRNA to Cancer数据库 (C2CDB),用于与癌症相关的circRNAs.
整合各种数据类型,为癌症circRNA研究提供分析工具.

主要方法:

开发了CircRNA到癌症数据库 (C2CDB).
来自30种癌症类型的318,158个与癌症相关的circRNA的综合数据.
包括关于序列,表达,miRNA结合,RNA结合蛋白相互作用,编码潜力,基修饰,突变和二次结构的信息.
从癌症circRNAs发表的文献中编译和提取内容.
开发了用于circRNA-miRNA ceRNA相互作用,编码和生物发生的综合分析工具.
标准化的circRNA命名法.

主要成果:

C2CDB包括来自30种癌症类型的瘤和相邻组织的318,158种与癌症相关的circRNA.
该数据库提供了关于circRNA特征,生物机制和策划文献的详细信息.
综合分析工具有助于研究circRNA的功能和相互作用.

结论:

C2CDB是癌症circRNA研究的一个有价值的,免费可访问的资源.
该平台解决了对综合数据和分析工具的需求,促进了对癌症中circRNAs的更深入理解.

更多相关视频

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

Identification of Circular RNAs using RNA Sequencing

Identification of Circular RNAs using RNA Sequencing

Published on: November 14, 2019

相关概念视频

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

lncRNA - Long Non-coding RNAs

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...